ADH5 and Fanconi anemia: These adverse effects can be scavenged by detoxifying enzymes, which have been the main focus of recent research in patients of a rare hereditary Fanconi anemia and animals with impaired expression of the DDR gene FANCD2 and the detoxifying enzymes ALDH2 and ADH5 [29,30].